Agios Pharmaceuticals' stock fell more than 15% after the FDA extended the Prescription Drug User Fee Act (PDUFA) date for mitapivat's supplemental New Drug Application (sNDA) for sickle cell disease to February 2027. The drug showed mixed results, missing its primary endpoint for reducing pain crises but demonstrating strong reductions in transfusion needs. The FDA delay is due to safety and Risk Evaluation and Mitigation Strategy (REMS) considerations, not efficacy concerns, with no new liver injury cases reported. The delay is seen as a temporary setback rather than a fundamental threat to approval, leading to a tentative 'Buy' rating for the stock.
Agios Pharmaceuticals' stock fell over 15% following the FDA delay on a sickle cell drug approval. For readers following the health sector, here is Pluang's market snapshot as of Oct 31, 2026 00:31 WIB: out of 150 priced US health stocks, 47 rose and 101 fell. Notable movers include DNA down 14.29% with 77% sell orders, TWST down 12.49% with 64% buy orders, and REGN up 11.31% with a typical hold time of 108 days.
The global Drone as First Responder (DFR) market, valued at $3 billion in 2025, is projected to grow to $11 billion by 2033 at a 17.7% CAGR. Growth is fueled by advancements in automated drone-in-a-box systems, beyond visual line of sight (BVLOS) ope...
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
